Pulmonary Circulation

Epidemiology and initial management of pulmonary arterial hypertension: real-world data from the Hellenic pulmOnary hyPertension rEgistry (HOPE)

Dynamic right ventricular–pulmonary arterial uncoupling during maximum incremental exercise in exercise pulmonary hypertension and pulmonary arterial hypertension

Hypoxia-induced pulmonary hypertension and chronic lung disease: caveolin-1 dysfunction an important underlying feature

The efficacy and safety of pulmonary vasodilators in patients with Fontan circulation: a meta-analysis of randomized controlled trials

Transition from parental prostacyclin to selexipag: a case series of five pulmonary arterial hypertension patients

Adverse physiologic effects of Western diet on right ventricular structure and function: role of lipid accumulation and metabolic therapy

SphK1/S1P mediates TGF-β1-induced proliferation of pulmonary artery smooth muscle cells and its potential mechanisms

Clinical and hemodynamic factors in predicting response to fluid challenge during right heart catheterization

Cardiac arrest and pulmonary hypertension in scurvy: a case report

The use of a durable right ventricular assist device for isolated right ventricular failure due to combined pre- and postcapillary pulmonary hypertension

Retinal vascular changes and right ventricular structure and function: the MESA-Right Ventricle and MESA-Eye studies

Case series of seven women with uterine fibroids associated with venous thromboembolism and chronic thromboembolic disease

Oral treprostinil in transition or as add-on therapy in pediatric pulmonary arterial hypertension

Mortality in US veterans with pulmonary hypertension: a retrospective analysis of survival by subtype and baseline factors

Clinical and hemodynamic benefit of macitentan and riociguat upfront combination in patients with pulmonary arterial hypertension

Drug repositioning in pulmonary arterial hypertension: challenges and opportunities

Elevated serum circ_0068481 levels as a potential diagnostic and prognostic indicator in idiopathic pulmonary arterial hypertension

Enhanced circulating levels of CD3 cells-derived extracellular vesicles in different forms of pulmonary hypertension

Severe pulmonary hypertension and reduced right ventricle systolic function associated with maternal mortality in pregnant uncorrected congenital heart diseases

Matrix metalloproteinase 7 in diagnosis and differentiation of pulmonary arterial hypertension

United States Pulmonary Hypertension Scientific Registry (USPHSR): rationale, design, and clinical implications

A checkpoint on innate myeloid cells in pulmonary arterial hypertension

Features of radiological and physiological findings in pulmonary capillary hemangiomatosis: an updated pooled analysis of confirmed diagnostic cases

Value of lung perfusion scintigraphy in patients with idiopathic pulmonary arterial hypertension: a patchy pattern to consider

Decreased collagen VI in the tunica media of pulmonary vessels during exposure to hypoxia: a novel step in pulmonary arterial remodeling

Pulmonary arterial hypertension in interferonophaties: a case report and a review of the literature

Metabolomics of exercise pulmonary hypertension are intermediate between controls and patients with pulmonary arterial hypertension

Pulmonary endarterectomy in a 12-year-old boy with multiple comorbidities

PPARβ/δ a potential target in pulmonary hypertension blighted by cancer risk

Switching to riociguat: a potential treatment strategy for the management of CTEPH and PAH

Acute vasoreactivity testing in pediatric idiopathic pulmonary arterial hypertension: an international survey on current practice

Reduced free-living activity levels in pulmonary arterial hypertension patients

Riociguat for the treatment of transthyretin cardiac amyloidosis: data from a named patient use program in Austria

Imatinib for right heart failure in COPD

Effects of oxygen therapy in a pediatric normoxemic patient with pulmonary arterial hypertension and congenital heart disease

Rates of hospitalization associated with the use of aldosterone receptor antagonists in patients with pulmonary arterial hypertension

Higher plasma fibroblast growth factor 23 levels are associated with a higher risk profile in pulmonary arterial hypertension

Idiopathic hypereosinophilic syndrome with pulmonary hypertension

Left ventricular peak early diastolic strain rate detected by two-dimensional speckle tracking echocardiography and disease severity in pre-capillary pulmonary hypertension

“Anagrelide-induced pulmonary arterial hypertension”: a rare case of drug-induced pulmonary arterial hypertension

Acute response to rapid iloprost inhalation using the Breelib™ nebulizer in pulmonary arterial hypertension: the Breelib™ acute study

The prognostic value of pulmonary artery compliance in cardiogenic shock

Myocardial bridge: an unrecognized cause of chest pain in pulmonary arterial hypertension

Multidisciplinary pulmonary embolism care: an exciting time to join the team

Reciprocal actions of constrictor prostanoids and superoxide in chronic hypoxia-induced pulmonary hypertension: roles of EETs

Proximal pulmonary arterial wall disease in patients with persistent pulmonary hypertension after successful left-sided valve replacement according to the hemodynamic phenotype

Long-term study of oral treprostinil to treat pulmonary arterial hypertension: dosing, tolerability, and pharmacokinetics